ArticleBloodPublished
Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Blood
- Published
- Topic
- Disease research
- Subject terms
- Humans; Lymphoma, Mantle-Cell; Piperidines; Pyrazoles; Pyrimidines; Adenine; Antineoplastic Combined Chemotherapy Protocols; Prognosis; Mutation; Aged; Aged, 80 and over; Female
- PubMed ID
- 40101138
- Added to directory
- Source checked